Is CBD Oil Legal in India: Legal Update and Buying Guide

Yes, CBD is legal in India, but only under specific conditions. This article breaks down exactly what those conditions are, what the law says, and what both consumers and brands need to know.

Understanding CBD and Benefits Of CBD Oil 

CBD, or Cannabidiol, is one of the active compounds found in the cannabis plant. Unlike THC (Tetrahydrocannabinol), which has psychoactive properties, CBD does not cause a high. This distinction is essential, as CBD oil offers various potential health benefits without the intoxicating effects commonly associated with cannabis.

In India, CBD oil is often used as a natural remedy for conditions such as:

• Chronic pain and inflammation
• Anxiety and depression
• Insomnia
• Epilepsy and seizure disorders
• Skin issues

While CBD oil has shown promising results as a natural health supplement, many Indians remain unsure about its legality due to the stringent laws surrounding cannabis.

Is CBD Legal in India?

Yes, CBD (Cannabidiol) is legal in India for medicinal and research purposes. The Ministry of Ayush has clarified that CBD itself is not classified as a drug. However, CBD products are listed under Schedule E-1 of the Drugs and Cosmetics Act, which means they require medical supervision.

The legal foundation lies in how Indian law defines cannabis. Under the NDPS Act 1985, only the flowering tops and resin of the cannabis plant are classified as narcotic substances. The leaves and seeds are excluded from this definition. Since CBD can be derived from the leaves, products manufactured from this part of the plant occupy a legal space provided they meet the right conditions.

Types of CBD Products Legal in India

Not all CBD products are treated equally under Indian law. Here’s how the main categories break down:

• CBD oil (leaf-derived, <0.3%THC): Legal for medicinal use when manufactured under an AYUSH licence and used with a valid prescription. This is the most common form of legal CBD in India.

• CBD capsules and wellness supplements: Permissible under the Drugs and Cosmetics Act when produced by licensed manufacturers and recommended by a registered medical practitioner.

• CBD topicals (creams, balms): Topical cannabis formulations can generally be sold over the counter and do not require a prescription, though the manufacturer must still hold an Ayush licence.

• Products derived from the cannabis flower or resin: Not legal for general consumer use. High-THC extracts, hash oil, and similar preparations remain classified as narcotics under the NDPS Act.

India’s Law on CBD Oil

The primary legislation is the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.

The Act draws a clear distinction: ganja (the flowering or fruiting tops of the cannabis plant) and charas (resin) are narcotic substances. Leaves and seeds, when separated from the flowering tops, are not. This single distinction is what makes leaf-derived CBD legal.

The Drugs and Cosmetics Act, 1940 then governs how CBD products can actually be manufactured and sold. Companies must hold a valid manufacturing licence from their state drug authority, and their products must meet quality and safety standards before entering the market.

While CDSCO oversees the approval of new drugs and clinical trials in India, not all cannabis-based products require direct CDSCO approval. Many cannabis-derived medicines are licensed under the AYUSH framework through state authorities, provided they meet applicable quality, safety, and regulatory requirements.

One additional layer: individual states retain the power to regulate cannabis leaves under their own excise laws. This means the legal landscape can vary slightly depending on where a product is being manufactured, sold, or transported.

NDPS Act and CBD Oil: Legal Guidelines in India

In India, cannabis laws are governed by the Narcotic Drugs and Psychotropic Substances Act (NDPS Act) of 1985. This act prohibits the recreational use of certain parts of the cannabis plant, specifically the flowering or fruiting tops, which contain high levels of THC and are more intoxicating. The NDPS Act restricts the use of cannabis for recreational purposes but allows some leeway for medicinal uses, depending on the plant part used and the extraction process.

The Key Legal Requirements to Follow as a CBD Brand

Operating legally as a CBD brand in India means meeting all of the following:

1. AYUSH Licence: Manufacturers must hold a valid licence from the Ministry of AYUSH. This is non-negotiable and is the primary marker of a compliant brand.

2. THC Limit: All products must contain a THC level below 0.3% of the permissible limit. Every batch should be tested.

3. Certificate of Analysis (COA): Third-party lab testing is essential. A COA verifies the cannabinoid profile, confirms THC levels, and validates the absence of contaminants. Brands that don’t publish COAs should be treated with caution.

4. Prescription Requirement: CBD products in India are not over-the-counter. Consumers are required to have a valid prescription from a licensed medical practitioner. Brands must build their sales process around this requirement.

5. Accurate Labelling: Products must clearly state what they contain, including cannabinoid content, THC percentage, batch number, and manufacturer details.

6. No Medical Claims Without Approval: Brands cannot make unverified therapeutic claims. All health-related communication must stay within the bounds of what regulatory approval permits.

Things to Absolutely Avoid

Both consumers and brands should steer clear of the following:

• Buying or selling CBD products without an AYUSH or equivalent state drug licence

• Products with THC content exceeding below the permissible limit, unless under strict regulatory and clinical oversight

• Sourcing CBD from the flowering tops or resin of the cannabis plant, this falls squarely under the NDPS Act’s definition of a narcotic

• Purchasing CBD from brands that don’t publish lab reports or COAs

• Making, sharing, or endorsing medical claims not backed by regulatory approval

• Importing CBD products without verifying their compliance with Indian law, foreign products are not automatically legal here

• Assuming a product is legal simply because it is sold online or marketed as “natural” or “hemp-based”

Understanding the Legal Use of CBD Oil for Medical Treatments

CBD oil is legally permitted for medical purposes in India if it meets specific guidelines. Here are the primary conditions under which CBD oil may be legally used:

Medical Prescription Requirement

The consumption of CBD oil with THC levels exceeding 0.3% is restricted to patients with a prescription from a licensed medical practitioner. If recommended by a healthcare provider, CBD oil can be used as a proprietary Ayurvedic medicine, particularly for pain management, anxiety, and epilepsy.

Approval from CDSCO

The Central Drugs Standard Control Organization (CDSCO) must approve cannabis-based medicinal products before they are available on the market. CBD oil that complies with these guidelines and has CDSCO approval can be legally sold and consumed for therapeutic purposes.

THC Content Limits

CBD oils with a THC concentration below 0.3% are generally considered safe and do not induce psychoactive effects. These products are allowed for medical use when they are produced under the guidelines of the Drugs and Cosmetics Act.

CBD Oil Laws in India vs Other Countries

India’s framework sits somewhere in the middle of the global spectrum.

• United States: Hemp-derived CBD was federally legalized under the 2018 Farm Bill, provided it contains no more than the permitted level of THC. Regulation varies by state, and the FDA continues to oversee CBD-containing therapeutic products.

• United Kingdom: CBD is permitted as a food supplement, subject to THC limits and compliance with the Food Standards Agency's Novel Food regulations.

• Canada: CBD is legal under the Cannabis Act, 2018 and is available through regulated channels for both medical and non-medical use.

• Germany: Medical cannabis has been legal since 2017. In 2024, Germany introduced a regulated framework allowing adult recreational cannabis use under specific conditions.

• Australia: Low-dose CBD was downscheduled in 2021, creating a pathway for certain pharmacy-supplied products, subject to regulatory approval requirements.

• China: Despite being a major hemp producer globally, CBD for human consumption remains illegal in China.

• India: cannabis-based medicines are available through regulated medical pathways and are typically prescribed under medical supervision.India's approach remains more conservative than that of many Western countries.

The trend across markets is toward greater access. India’s framework is cautious but not regressive and is evolving.

Future of CBD Legalisation in India

The direction is cautiously positive.

India has a long, documented history of cannabis use in traditional medicine - bhang, documented in Ayurvedic texts, remains legal in many states. India's regulatory approach to CBD and cannabis-based medicines continues to evolve.

Government agencies, researchers, and healthcare professionals are increasingly exploring their therapeutic potential, while efforts continue to improve regulatory clarity and patient access within a controlled medical framework.